大湖健康产业股份有限公司2025年度拟不进行利润分配及资本公积转增股本公告深度解读

公告要点概述

• 公司股票代码：600257
• 公司简称：大湖股份
• 公告编号：2026-011
• 公告时间：2026年4月8日

关键内容详解

• 2025年度利润分配及资本公积转增股本决议：
  大湖健康产业股份有限公司董事会决定，2025年度不进行利润分配，也不进行资本公积转增股本。
• 财务状况：
  • 经中审众环会计师事务所（特殊普通合伙）审计，公司2025年度母公司合并报表中期末未分配利润为 -80,414,231.02元，合并报表中归属于上市公司股东的净利润为 5,065,308.35元，累计可供分配利润为 -296,898,856.57元。
  • 公司母公司未分配利润为负数，累计可供分配利润也为负数，说明公司整体盈利状况仍不佳，尚未恢复到能够分配利润的水平。
• 董事会决议：
  • 董事会于2026年4月7日召开第九届董事会第二十三次会议，以5票同意、0票弃权、0票反对的表决结果审议通过本议案。
  • 该利润分配预案符合公司实际情况、《公司章程》及相关法律法规。
• 合规性及风险警示：
  • 公司未触及《上海证券交易所股票上市规则》第9.8.1条第一款第（八）项规定的可能被实施其他风险警示的情形，意味着虽然公司暂时不分红，但未被监管机构列为特别风险。
• 后续程序：
  • 本次利润分配预案尚需提交2025年年度股东大会审议。

对股东及投资者的影响

• 股东须知：
  • 本年度公司不进行现金分红，亦不以资本公积转增股本，股东不会获得任何分红或送股。
  • 公司财务状况未完全改善，未分配利润和累计可供分配利润均为负数，表明公司盈利能力仍需提升。
  • 未触及风险警示条款，意味着公司运营尚未出现重大异常，但分红政策的持续“暂停”可能影响投资者信心。
  • 该公告可能对公司股价造成一定压力，尤其是偏好分红的投资者可能会重新评估持仓。
  • 最终是否执行该预案，仍需2025年年度股东大会表决。投资者应密切关注后续股东大会的进展。

总结

大湖健康产业股份有限公司2025年度不进行利润分配及资本公积转增股本，反映出公司财务状况仍未达到分红标准。虽然公司未被监管列为特别风险，但持续不分红可能影响部分投资者信心，需关注后续股东大会审议结果及公司未来经营情况。

免责声明：本文内容仅供参考，不构成任何投资建议。投资者应结合自身情况及最新公告，审慎决策。公司未来经营及利润分配政策可能发生变化，请持续关注公司后续公告。

English Version

In-depth Interpretation: Dahu Health Industry Co., Ltd.’s 2025 No Dividend Distribution and Capital Reserve Transfer Announcement

Summary of Key Points

• Stock Code: 600257
• Stock Name: Dahu Health
• Announcement No.: 2026-011
• Announcement Date: April 8, 2026

Detailed Key Content

• 2025 Dividend & Capital Reserve Plan:
  The board of Dahu Health Industry Co., Ltd. has decided not to distribute dividends nor to transfer capital reserves into share capital for 2025.
• Financial Status:
  • Audited by Zhongshen Zhonghuan CPA firm: End-of-year undistributed profit (parent company consolidated) is -80,414,231.02 RMB, net profit attributable to listed company shareholders is 5,065,308.35 RMB, cumulative distributable profit is -296,898,856.57 RMB.
  • The company’s undistributed profit is negative. Cumulative distributable profit is negative as well, indicating ongoing weak profitability.
• Board Resolution:
  • Board meeting held on April 7, 2026: 5 votes in favor, 0 abstentions, 0 against. The proposal complies with company bylaws and relevant laws.
• Compliance & Risk Warning:
  • The company has not triggered any risk warning clauses as per Shanghai Stock Exchange Listing Rules Article 9.8.1(8), meaning there are no regulatory flags despite the lack of dividend.
• Next Steps:
  • This dividend plan still requires approval at the 2025 annual shareholders’ meeting.

Implications for Shareholders & Investors

• Shareholder Notes:
  • No cash dividend or bonus shares will be distributed this year.
  • Negative undistributed and distributable profits signal continued weak profitability.
  • No regulatory risk warning, but continued suspension of dividend may affect investor confidence.
  • This announcement may pressure share price, especially among dividend-focused investors.
  • Final implementation depends on shareholder meeting approval; investors should monitor further developments.

Conclusion

Dahu Health Industry Co., Ltd.’s decision not to distribute dividends or transfer capital reserves in 2025 reflects its ongoing financial challenges. Although there are no regulatory risk flags, continuous suspension of dividends may impact investor sentiment. Investors should pay close attention to subsequent shareholder meeting outcomes and future company performance.

Disclaimer: The content of this article is for reference only and does not constitute investment advice. Investors should make prudent decisions based on their own circumstances and the latest company announcements. The company’s future business and dividend policy may change; please continue to follow official updates.

View 大湖股份 Historical chart here